S. Zamir

Early Biomarkers from Conventional and Delayed-Contrast MRI to Predict the Response to Bevacizumab in Recurrent High-Grade Gliomas

D. Yekutieli, D. Nass, A. Kanner, 2016, American Journal of Neuroradiology.